Cargando…

AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY

Detalles Bibliográficos
Autores principales: Conti, C.B., Mainardi, E., Soro, S., Testa, S., De Silvestri, A., Drago, A., Cereatti, F., Grassia, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451197/
http://dx.doi.org/10.1016/S1590-8658(21)00605-8
_version_ 1784569791913132032
author Conti, C.B.
Mainardi, E.
Soro, S.
Testa, S.
De Silvestri, A.
Drago, A.
Cereatti, F.
Grassia, R.
author_facet Conti, C.B.
Mainardi, E.
Soro, S.
Testa, S.
De Silvestri, A.
Drago, A.
Cereatti, F.
Grassia, R.
author_sort Conti, C.B.
collection PubMed
description
format Online
Article
Text
id pubmed-8451197
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editrice Gastroenterologica Italiana S.r.l.
record_format MEDLINE/PubMed
spelling pubmed-84511972021-09-20 AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY Conti, C.B. Mainardi, E. Soro, S. Testa, S. De Silvestri, A. Drago, A. Cereatti, F. Grassia, R. Dig Liver Dis Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD Editrice Gastroenterologica Italiana S.r.l. 2021-09 2021-09-20 /pmc/articles/PMC8451197/ http://dx.doi.org/10.1016/S1590-8658(21)00605-8 Text en Copyright © 2021 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD
Conti, C.B.
Mainardi, E.
Soro, S.
Testa, S.
De Silvestri, A.
Drago, A.
Cereatti, F.
Grassia, R.
AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title_full AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title_fullStr AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title_full_unstemmed AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title_short AF.42 SARS-COV-2 ANTIBODIES POSITIVITY IN IBD POPULATION AND CORRELATION WITH THERAPY: A PILOT STUDY
title_sort af.42 sars-cov-2 antibodies positivity in ibd population and correlation with therapy: a pilot study
topic Abstracts of the 27th National Congress of Digestive Diseases 2021 – FISMAD
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451197/
http://dx.doi.org/10.1016/S1590-8658(21)00605-8
work_keys_str_mv AT conticb af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT mainardie af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT soros af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT testas af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT desilvestria af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT dragoa af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT cereattif af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy
AT grassiar af42sarscov2antibodiespositivityinibdpopulationandcorrelationwiththerapyapilotstudy